Dr Vickers is the President and CEO of Faze Medicines. He has more than two decades’ experience in the biotech and pharmaceutical industry, was previously President and CEO of Northern Biologics, and has held leaderships positions in Research & Development at Shire, Merck, Pfizer, Boehringer-Ingelheim and Resolvyx Pharmaceuticals. He is a member of the board of both Revance Therapeutics and AVROBIO.
Dr Vickers holds a PhD in Biochemistry from the University of Toronto and a BSc in Applied Biochemistry from the University of Salford, United Kingdom. He was a Visiting Fellow at the National Cancer Institute in Bethesda, Maryland, prior to entering the pharmaceutical industry.